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INTRODUCTION
Angiosarcomas are extremely rare high-grade malignant
tumors, accounting for less than 2% of soft tissue sarcomas
(1). Approximately one third of angiosarcomas occur in skin,
one third in soft tissue, and remaining one third in other sites
including breast, liver, and bone. Cutaneous angiosarcoma
occurs most commonly on the face and scalp in elderly patients
and is also seen in association with chronic lymphedema (2). 
It is estimated that less than 1% of all spontaneous pneu-
mothorax are tumor-associated (3). Development of a spon-
taneous pneumothorax in patients with metastatic soft tissue
sarcomas has been described in advanced diseases or during
cytotoxic chemotherapy. However, the spontaneous bilateral
pneumothorax is a rare complication of cancer chemotherapy.
Here we report a case of bilateral spontaneous pneumothorax
after systemic chemotherapy in a male patient with a localized
angiosarcoma of the scalp.
CASE REPORT 
A 68-yr-old man is presented with an erythematous patchy
induration on his scalp. There were no history of smoking,
radiation, and trauma. There were no evidence of underlying
lung lesion or any metastasis on his chest radiography. On
examination, there were 3×4 cm-sized pink-purple nodules
with several small satellite lesions on scalp. There were no
palpable lymph nodes on both supraclavicular and neck re-
gions. Biopsy of the lesion showed a network of intercon-
necting capillary lumens lined by atypical endothelial cells
with hyperchromic pleomorphic nuclei and collagen bundles
in the deep dermis. The lining atypical endothelial cells
showed a positive reactivity for CD34 and vimentin. Magnetic
resonance imaging (MRI) revealed a tumor with an irregular
boundary on vertex of parietal scalp (Fig. 2). Underlying
cortical bones were intact and a mass containing a central
necrotic portion was invading the skin, subcutaneous layer,
and muscle layer. The patient underwent a wide excision of
parietal scalp and a split-thickness skin graft from the thigh.
On pathologic examination, a fragment of the scalp measuring
10×7.5×1 cm was indurated with central ulceration. On
cross-section, the scalp was thickened and diffusely infiltrated
by an ill-defined tannish firm lesions (Fig. 3). Numerous
irregular shaped anastomosing vascular channels with the
appearance of dissecting collagen bundles were seen in the
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Bilateral Spontaneous Pneumothorax During Cytotoxic Chemotherapy
for Angiosarcoma of the Scalp
: A Case Report
Spontaneous pneumothorax is a rare manifestation of metastatic lung cancers
and described in advanced diseases or during cytotoxic chemotherapy which is
manifested by sudden onset of dyspnea. The cause or mechanism of sponta-
neous pneumothorax has been unknown, as well as the association with site of
metastases or type of cancers or side effect of chemotherapeutic drugs has been
reported rarely. A 68-yr-old man underwent excision of angiosarcoma of the scalp.
Chest radiography did not show any evidence of possible metastatic lung lesion
at that time. Therefore, systemic doxorubicin and dacarbazine were given. After
nineteen days of chemotherapy, he developed a bilateral spontaneous pneumotho-
rax and palpable cervical lymph nodes. Both parietal and visceral pleura were
intact and showed no evidence of metastatic and pathologic lesions on thoraco-
scopic evaluation. The patient managed with bilateral tube thoracostomy and both
lungs were expanded. Lymph nodes became unpalpable during three cycles of
the paclitaxel and doxorubicin, however, bilateral lung metastases were developed
and progressed despite chemotherapy. The patient died due to respiratory failure
after five months. This report underlines that spontaneous pneumothorax can
occur as the first manifestation of metastatic angiosarcoma even if imaging studies
do not show of a metastatic lesion.
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dermis. Microscopy showed anastomotic channels lined by
the endothelial cells and a cystic change with hemorrhage
(Fig. 4). Tumor cells showed a positive immunohistochemi-
cal staining for factor 8, CD34, and CD31 (Fig. 5). Due to
diffuse local spread of tumor, complete excision was impos-
sible. The patient received combined systemic chemotherapy
of doxorubicin (50 mg/m
2) and dacarbazine (400 mg/m
2).
Nineteen days after the systemic chemotherapy, he was ad-
mitted to an emergency department with bilateral sponta-
neous pneumothorax (Fig. 1), and palpable cervical lymph
Fig. 1. Bilateral pneumothorax with both costophrenic angle blunt-
ing are observed.
Fig. 3. On cross section, the parietal scalp is markedly indurated
and diffusely infiltrated by an ill-defined tannish firm lesion.
Fig. 2. T1-weighted sagittal view MRI shows heterogeneous sig-
nal intensity mass with an irregular boundary on the vertex of pari-
etal scalp (arrow). Underlying cortical bone is intact and a mass
containing a central necrotic portion is invading the skin, subcu-
taneous layer, and muscle layer.
Fig. 4. Numerous irregular shaped anastomosing vascular chan-
nels are lined by endothelial cells with a cystic change and hem-
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nodes. Both parietal and visceral pleura were intact and showed
no evidence of metastatic lesions on thoracoscopic evaluation.
The patient was managed with bilateral closed thoracostomy
and both lungs were expanded. Also he  underwent pleurode-
sis with bleomycin and received three cycles of combined
chemotherapy of paclitaxel (135 mg/m
2) and doxorubicin
(50 mg/m
2). Lymph nodes disappeared, however, bilateral
lung metastases were developed and progressed despite of
systemic chemotherapy. He died of respiratory failure after
five months.
DISCUSSION 
Angiosarcomas are extremely rare high-grade malignant
tumors arising from the vascular endothelium (4). Approxi-
mately half of the cases involve  head and neck regions. The
disease occurs most frequent in the sixth and seventh decades
of life, with a male predilection (5).
Angiosarcomas are highly invasive tumors with the capacity
to spread locally as well as distantly and have a rapid clinical
course. Most angiosarcomas are metastasized at the time of
diagnosis and have a poor prognosis of 2-24 months of sur-
vival from the time of detection due to frequent recurrence
and early hematogenous metastases. The most common dis-
tant metastatic sites include the lung, liver, lymph nodes, and
the skin (5, 6). 
Kitagawa et al. (7) subdivided 95 autopsies of patients with
angiosarcomas into a scalp group and a non-scalp group. The
patients of the scalp group had more frequent pulmonary com-
plications including pneumothorax, pulmonary hemorrhage,
atelectasis, and pneumonia. In particular, pneumothorax was
observed only in the scalp group, and was implicated in the
extremely poor survival. Therefore, angiosarcomas of the scalp
tend to metastasize to the lung, especially to the subpleural
or pleural space, where these metastatic tumors are prone to
necrosis, causing characteristic pulmonary complications. 
Several theories regarding possible mechanisms of the bi-
lateral pneumothorax in angiosarcomas have been put for-
ward. First, the rupture of a subpleural bleb in a patient with
an underlying chronic pulmonary disease is possible. Second,
tumor nodules may act as ball valves to produce a partial
bronchiolar obstruction and hyperinflation of alveoli. The
rupture of an emphysematous bulla in an overexpanded por-
tion of the lung produces a pneumothorax (8). Therefore, the
disruption of peripheral visceral pleura or peripheral bron-
chioles causes a bronchopleural fistula (9). In our patient,
thoracoscopic evaluation did not show  any definite metastatic
nodule or bulla. Third, the chemosensitivity of cancer may
be considered. Tumors with an increased risk of developing
a pneumothorax include Ewing’s sarcoma, Wilms’ tumor,
teratoma, and synovial sarcoma (10). Osteosarcomas are
thought to be the most common metastatic tumor causing
a spontaneous pneumothorax (11). Fourth, the side effects
of chemotherapeutic agents have been considered due to the
temporal relationship between the use of combination chemo-
therapy and the development of pneumothorax. For example,
Devereux et al. suggested that doxorubicin was the chemother-
apeutic agent most likely to impair the wound healing with
tissue repair, and may consequently predispose patients with
pulmonary metastasis to pneumothorax (12). In this case,
doxorubicin was included in the cytotoxic regimen, however,
it is difficult to relate its direct effect on pneumothorax.
Until now, no established chemotherapy has been available
for angiosarcomas, since systemic chemotherapy is ineffective
in the disease with metastatic lesions. Therapy for angiosar-
comas involves an early wide local excision, if possible. Early
surgery and wide-field postoperative radiation therapy may
offer the highest cure rate (1). Recently, however, paclitaxel
showed a good response in 28 patients with scalp angiosar-
comas with complete resolution of skin nodules and a par-
tial response to metastatic lung lesions in phase II trials (13).
Our patient was treated with paclitaxel (Taxol
�) at a dose of
135 mg/m
2 for three cycles. Lymph nodes were not palpated
after three cycles with systemic chemotherapy but lung metas-
tases were developed lately.
Fenlon et al. stated that a pneumothorax resulting from a
bronchopleural fistula complicating chemotherapy may prove
to be resistant to conventional treatment (repeated closed-tube
thoracostomy, suction drainage, and pleurodesis), and thus
required a bilateral thoracostomy and pleurectomy (10). 
Metastases are sometimes confirmed by high-resolution
computed tomography (CT) or transthoracic needle aspira-
tion biopsy. Metastatectomy via thoracotomy or median
sternotomy are sometimes employed (14). Early detection
Fig. 5. Tumor cells show a positive immunohistochemical staining
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of lung metastases is difficult, and Furrer et al. suggested
that imaging studies such as chest radiography and CT are
suboptimal for detecting micro-lesions and that sometimes
pneumothorax could be the first and only evidence for meta-
stases (9).
In this case, metastatic lesions could not be noted in the
initial chest radiography and CT. However, with the delayed
detection of diffuse bilateral lung metastases, we are able to
presume that micrometastases were already occurred even
before it could be detected by imaging studies.
This report underlines that pneumothorax can occurs as the
first manifestation of metastatic angiosarcoma even if imaging
studies are not indicative of metastatic disease.
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